← Leaderboards
Alan M Gewirtz
University Of Pennsylvania
$7,607,971
Attributed
$7,607,971
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.5M · FY2005–09$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$16,146,045 · 7
By mechanism
P01$9,084,764 · 2
T32$2,303,317 · 1
K12$1,894,027 · 1
R01$1,853,421 · 2
P30$1,010,516 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Ian Alexander Blair$30,276,296
- Robert H Vonderheide$28,425,019
- Francesca Catella-Lawson$1,843,768
- Jerry D Glickson$20,468,757
- Xiaowei Xu$9,845,570
Others in their field
Top investigators on “Gene Expression”
- Jeffrey P Krischer · University Of South Florida$137,481,663
- Eric S Lander · Whitehead Institute For Biomedical Res$128,154,716
- Stacey Gabriel · Massachusetts Institute Of Technology$86,302,566
- Bruce W Stillman · Cold Spring Harbor Laboratory$82,324,317
- Michael P Snyder · Yale University$75,701,723
- Ronald G Crystal · Weill Medical College Of Cornell Univ$74,774,977
Research focus
Gene ExpressionAntisense Nucleic AcidClinical ResearchHematopoiesisHuman SubjectDrug Screening /EvaluationGenetic TranscriptionDrug Design /Synthesis /ProductionOligonucleotidesProtooncogeneMessenger RnaPharmacokineticsAntineoplasticsNucleic Acid HybridizationTrainingLaboratory MouseResearch PersonnelBone Marrow PurgingNeoplasm /Cancer PharmacologyGene TargetingProgramsAcute LeukemiaBaseMalignant Neoplasms
Grant awards (40)
Cellular molecular biologics in clinical cancer research$440,111
K12 · FY2009 · CA · contact PI
Hematopoiesis training grant$152,903
T32 · FY2009 · DK · contact PI
Cellular molecular biologics in clinical cancer research$810,000
K12 · FY2008 · CA · contact PI
Hematopoiesis training grant$248,632
T32 · FY2008 · DK · contact PI
Examing Oligonucleotide Effects on Gene Expression$1,252,378
P01 · FY2007 · CA · contact PI
CELLULAR/MOLECULAR BIOLOGICS IN CLINICAL CANCER RESEARCH$643,916
K12 · FY2007 · CA · contact PI
Hematopoiesis training grant$318,126
T32 · FY2007 · DK · contact PI
Developing Nucleic Acid Therapeutics$267,510
R01 · FY2007 · CA · contact PI
Examing Oligonucleotide Effects on Gene Expression$1,256,831
P01 · FY2006 · CA · contact PI
Hematopoiesis training grant$308,104
T32 · FY2006 · DK · contact PI
Developing Nucleic Acid Therapeutics$275,500
R01 · FY2006 · CA · contact PI
Examing Oligonucleotide Effects on Gene Expression$1,254,291
P01 · FY2005 · CA
Hematopoiesis training grant$297,437
T32 · FY2005 · DK
Developing Nucleic Acid Therapeutics$282,130
R01 · FY2005 · CA
Examing Oligonucleotide Effects on Gene Expression$1,221,960
P01 · FY2004 · CA
Developing Nucleic Acid Therapeutics$282,130
R01 · FY2004 · CA
Hematopoiesis training grant$223,902
T32 · FY2004 · DK
Examing Oligonucleotide Effects on Gene Expression$1,213,732
P01 · FY2003 · CA
Developing Nucleic Acid Therapeutics$282,130
R01 · FY2003 · CA
HEMATOPOIESIS TRAINING GRANT$204,808
T32 · FY2003 · DK
CORE--STEM CELL FACILITY$228,564
P30 · FY2002 · CA
REGULATORY ROLE OF PROTO-ONCOGENES IN NORMAL AND MALIGNANT HEMATOPOIESIS$197,196
R01 · FY2002 · CA
HEMATOPOIESIS TRAINING GRANT$145,869
T32 · FY2002 · DK
EXAMINING OLIGONUCLEOTIDE EFFECTS ON GENE EXPRESSION$51,013
P01 · FY2002 · CA
VAV ANTISENSE ODN--A NOVEL THERAPEUTIC FOR HUMAN LEUKEMIAS$0
P01 · FY2002 · CA
EXAMINING OLIGONUCLEOTIDE EFFECTS ON GENE EXPRESSION$1,104,586
P01 · FY2001 · CA
CORE--STEM CELL FACILITY$276,694
P30 · FY2001 · CA
CORE--STEM CELL FACILITY$228,564
P30 · FY2001 · CA
REGULATORY ROLE OF PROTO-ONCOGENES IN NORMAL AND MALIGNANT HEMATOPOIESIS$197,196
R01 · FY2001 · CA
HEMATOPOIESIS TRAINING GRANT$185,594
T32 · FY2001 · DK
VAV ANTISENSE ODN--A NOVEL THERAPEUTIC FOR HUMAN LEUKEMIAS$165,355
P01 · FY2001 · CA
EXAMINING OLIGONUCLEOTIDE EFFECTS ON GENE EXPRESSION$37,763
P01 · FY2001 · CA
VAV ANTISENSE ODN--A NOVEL THERAPEUTIC FOR HUMAN LEUKEMIAS$0
P01 · FY2001 · CA
EXAMINING OLIGONUCLEOTIDE EFFECTS ON GENE EXPRESSION$1,108,048
P01 · FY2000 · CA
CORE--STEM CELL FACILITY$276,694
P30 · FY2000 · CA
HEMATOPOIESIS TRAINING GRANT$217,942
T32 · FY2000 · DK
VAV ANTISENSE ODN--A NOVEL THERAPEUTIC FOR HUMAN LEUKEMIAS$215,980
P01 · FY2000 · CA
VAV ANTISENSE ODN--A NOVEL THERAPEUTIC FOR HUMAN LEUKEMIAS$165,355
P01 · FY2000 · CA
REGULATORY ROLE OF PROTO-ONCOGENES IN NORMAL AND MALIGNANT HEMATOPOIESIS$69,629
R01 · FY2000 · CA
EXAMINING OLIGONUCLEOTIDE EFFECTS ON GENE EXPRESSION$37,472
P01 · FY2000 · CA